Author:
Goyal Navin,Mohamed Khadeeja,Rolfe Katie,Sahota Satty,Ernest Terry,Duparc Stephan,Taylor Maxine,Casillas Linda,Koh Gavin C. K. W.
Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. FDA/CDER, September 1997.Guidance for industry, extended release oral dosage forms: development, evaluation, and application of in vitro/in vivo correlations. Available from
https://www.fda.gov/downloads/drugs/guidances/ucm070239.pdf
. Accessed February 2018.
2. Parr A, Gupta M, Montague TH, Hoke F. Re-introduction of a novel approach to the use of stable isotopes in pharmacokinetic studies. AAPS J. 2012;14(3):639–45.
3. Baillie TA. The use of stable isotopes in pharmacological research. Pharmacol Rev. 1981;33(2):81–132.
4. Pieniaszek HJ Jr, Mayersohn M, Adams MP, Reinhart RJ, Barrett JS. Moricizine bioavailability via simultaneous, dual, stable isotope administration: bioequivalence implications. J Clin Pharmacol. 1999;39(8):817–25.
5. Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, et al. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet. 2014;383(9922):1049–58.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献